The study on the Global Gerd Drugs And Devices Market is the latest report covering the impact analysis of the currently ongoing COVID-19 pandemic. The pandemic has directly affected the market by causing disruptions in the global supply chains and indirectly by inducing financial difficulties. The Gerd Drugs And Devices market has witnessed dynamic changes in trends and demands owing to the ongoing COVID-19 pandemic. The report provides a detailed outlook on how the pandemic has affected the key segments of the Gerd Drugs And Devices industry.
The report includes an in-depth impact analysis of the COVID-19 pandemic on the overall Gerd Drugs And Devices industry. The report contains unbiased industry expert opinions on the current market scenario, past market performance, production consumption rates, demand supply ratio, and revenue generation forecasts over the estimated period.
Gastroesophageal Reflux Disease is growing due to the intake of analgesics, smoking, decrease in the prevalence of Helicobacter pylori infection, consumption of certain types of food and drinks, high body mass index (BMI), family history of GERD, and limited physical activity. The growing incidence of the disease will drive the demand for the GERD drug and devices market.
Get a sample of the report : https://www.emergenresearch.com/request-sample/383
For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, device type, and region:
Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
- Oral
- Parenteral
Drug Type Outlook (Revenue, USD Billion; 2017-2027)
- H2 Receptor Antagonist
- Proton Pump Inhibitor (PPIs)
- Antacids
Device Type Outlook (Revenue, USD Billion; 2017-2027)
- MUSE –Medigus Ultrasonic Surgical Endostapler
- LINX Management System
- Stretta Therapy
- Bravo Reflux Testing System
- Digitrapper reflux testing system
- Others
Market Scope:
One of the report’s central components is the broad Gerd Drugs And Devices market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the Gerd Drugs And Devices market players.
The factors impacting the growth of the market are the rise in the trend of self-medication and increased awareness of GERD. Moreover, the constant occurrence of GERD disorders, as well as changes in lifestyle, are propelling the market demand
Request a discount on the report : https://www.emergenresearch.com/request-discount/383
Some Key Highlights from the Report
In November 2020, Sandoz Inc. announced it had shipped pantoprazole sodium to supply the hospitals for injection, 40 mg to Civica Rx. It is a part of a multiyear collaboration for the reduction in supply shortages with several other pipeline medicines.
H2 blockers are a group of drugs that reduces the amount of acid produced by the cell lining of the stomach. They are also known as histamine H2-receptor antagonists but are also known as H2 blockers. They include ranitidine, cimetidine, nizatidine, and famotidine, among others.
The MUSE or Medigus Ultrasonic Surgical Endostapler is an extensive endoscopic device that incorporates the latest technological advancement for the delivery of patient-friendly option for Transoral Fundoplication, the procedure intended for the treatment of GERD.
North America held the largest share, with the U.S. contributing the major revenue share. The rise in the geriatric population in the region, which is prone to acid reflux and development in heartburn, will drive the demand of the Gastroesophageal Reflux Disease Drugs and Devices market
Key participants include Johnson Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.
Key Points of Gerd Drugs And Devices Market:
Extensive coverage of the analysis of the Gerd Drugs And Devices market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Gerd Drugs And Devices market
Complete data about the key manufacturers and vendors in the Gerd Drugs And Devices market
Read More: https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Related reports:
cardiac monitoring cardiac rhythm management devices market
industrial microbiology market
in silico drug discovery market
gerd drugs and devices market
spinal fusion devices market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
